Wellness App for Sleep Disturbance in Hematological Cancer Patients (CTMS# 22-0116)
Lay Description
Are you undergoing treatment for a blood cancer diagnosis and experiencing poor sleep?
Researchers at the Mays Cancer Center are seeking US-based adults diagnosed with blood cancer and experiencing sleep disturbance to participate in a 20-week remote study testing a digital wellness intervention. Participants in this study will be assigned to use one of two digital wellness apps 10 minutes per day over 8-weeks to determine if it can help improve sleep, immune function, and other psychological and emotional outcomes.
This study is completely remote (there are no in-person visits with the research team) and patients from across the USA are invited.
Participation involves:
- One brief 30-minute virtual meeting with a research assistant
- Completing online surveys
- Providing three blood samples over the 20-week study at a lab close to you
- Tracking sleep using a small device and daily diary
- Using a wellness app for 10 minutes per day for 8-weeks
Participants who qualify and are enrolled in the study will be compensated at regular intervals, up to $100 total.
Category
- Cancers and Other Neoplasms
- Acute Lymphoblasic Leukemia
- Acute Myeloid Leukemia
- Hematological Malignancy
- Leukemia, other
- Lymphoid Leukemia
- Lymphoma
- Multiple Myeloma
- Myeloid and Monocytic Leukemia
- Myeloma
- Other Hematopoietic
- IRB Number
- 20220567HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- 18
- Eligible Genders
- All
- Accepts Healthy Volunteers
Inclusion Criteria
You may qualify for the study if you:
- Are over 18 and reside in the USA
- Have a blood cancer diagnosis and are currently receiving treatment
- Experience sleep disturbance, such as difficulty falling asleep, staying asleep, or poor quality of sleep
- Own a smartphone
Are willing to complete the study procedures
Exclusion Criteria
Other Exclusion Criteria:
- Not residing in the USA
- Non-English speaking
- Not in active treatment or not on stable treatment
- Diagnosed or at high risk for sleep apnea
Regular use of sleep aids on 3 or more nights per week
Study Design
Arm Groups
Study Contact
Frances Crawford
(210) 450-5037
crawfordf1@uthscsa.edu
Sonia Creighton
(210) 450-1366
creighton@uthscsa.edu
Myrna Montenegro
(210) 450-5954
montenegro@uthscsa.edu
Courtney Nichols
(210) 450-1794
nicholsc2@uthscsa.edu
Mailbox Ctrc Regulatory Affairs
regaffapp@uthscsa.edu
Kathleen Rodriguez
(210) 450-1365
rodriguezk3@uthscsa.edu
Benjamin Schleif
(210) 450-1366
schleifb@uthscsa.edu
Morgan Seekatz
(210) 450-1133
seekatz@uthscsa.edu
Jillian Johnson
+1 (814) 424-5601
johnsonj27@uthscsa.edu
Principal Investigator
Jennifer Huberty